Literature DB >> 26034441

Clinical outcomes following collagenase injections compared to fasciectomy in the treatment of Dupuytren's contracture.

Raghuveer C Muppavarapu1, Michael J Waters2, Matthew I Leibman3, Mark R Belsky3, David E Ruchelsman4.   

Abstract

INTRODUCTION: The aim of this study is to compare the efficacy of collagenase injections with that of fasciectomy in the treatment of Dupuytren's contracture.
METHODS: This is a case-control retrospective study. We reviewed the electronic medical records from January 2009 through January 2013, identifying 142 consecutive patients who underwent either fasciectomy or collagenase injection. Exclusion criteria for both groups were age <18 years, pregnant women, and arthroplasty or arthrodesis of the treated joint. Follow-up data beyond 1-year duration was available for 117 of the patients: 44 patients who had undergone fasciectomy, and 73 patients who had received collagenase injection. The primary outcome measure in this study was resolution of joint contracture to 0-5° deficit of full extension. Data was analyzed using two-sample t tests for continuous data and chi-square test for categorical data. A significant P value was set at <0.05.
RESULTS: At the latest follow-up, significantly more joints treated with fasciectomy met the primary outcome measure. Metacarpophalangeal (MP) joints responded better than the proximal interphalangeal (PIP) joints for both treatments. At the latest follow-up (14.2 months for collagenase, 16.3 months for fasciectomy), 46 % of MP joints treated with collagenase and 68 % of MP joints treated with fasciectomy maintained resolution of joint contracture. Sub-analysis of the affected joints based on the severity of initial contracture demonstrated that MP and PIP joints with contractures <45° responded better than more severely contracted joints (>45°).
CONCLUSIONS: Fasciectomy yields a greater mean magnitude of correction for digital contractures at the latest follow-up when compared to collagenase. Both treatments were more effective for treatment of MP joint contracture compared to PIP joint contracture. LEVEL OF EVIDENCE: Level III, therapeutic.

Entities:  

Keywords:  Collagenase; Dupuytren’s disease; Faciectomy; Finger joint contracture; Xiaflex

Year:  2015        PMID: 26034441      PMCID: PMC4447679          DOI: 10.1007/s11552-014-9704-0

Source DB:  PubMed          Journal:  Hand (N Y)        ISSN: 1558-9447


  27 in total

Review 1.  Collagenolytic proteases from bacteria.

Authors:  K Watanabe
Journal:  Appl Microbiol Biotechnol       Date:  2003-10-11       Impact factor: 4.813

2.  Fasciectomy for treatment of Dupuytren's disease and early complications.

Authors:  G R Sennwald
Journal:  J Hand Surg Am       Date:  1990-09       Impact factor: 2.230

3.  Results of partial fasciectomy for Dupuytren disease in 261 consecutive patients.

Authors:  J Henk Coert; Juan P Barret Nérin; Marcel F Meek
Journal:  Ann Plast Surg       Date:  2006-07       Impact factor: 1.539

Review 4.  Dupuytren disease: Anatomy, pathology, presentation, and treatment.

Authors:  Ghazi M Rayan
Journal:  J Bone Joint Surg Am       Date:  2007-01       Impact factor: 5.284

5.  The effect of night extension orthoses following surgical release of Dupuytren contracture: a single-center, randomized, controlled trial.

Authors:  Julie Collis; Shirley Collocott; Wayne Hing; Edel Kelly
Journal:  J Hand Surg Am       Date:  2013-07       Impact factor: 2.230

6.  Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren's disease.

Authors:  David Gilpin; Stephen Coleman; Stephen Hall; Anthony Houston; Jeff Karrasch; Nigel Jones
Journal:  J Hand Surg Am       Date:  2010-12       Impact factor: 2.230

7.  Efficacy and tolerability of Day 2 manipulation and local anaesthesia after collagenase injection in patients with Dupuytren's contracture.

Authors:  C J Manning; R Delaney; M J Hayton
Journal:  J Hand Surg Eur Vol       Date:  2013-05-29

8.  The effect of a therapy protocol for increasing correction of severely contracted proximal interphalangeal joints caused by dupuytren disease and treated with collagenase injection.

Authors:  Terri M Skirven; Abdo Bachoura; Sidney M Jacoby; Randall W Culp; A Lee Osterman
Journal:  J Hand Surg Am       Date:  2013-03-06       Impact factor: 2.230

Review 9.  Diagnosis and indications for surgical treatment.

Authors:  A C Smith
Journal:  Hand Clin       Date:  1991-11       Impact factor: 1.907

10.  Collagenase clostridium histolyticum for dupuytren contracture: patterns of use and effectiveness in clinical practice.

Authors:  Clayton A Peimer; Paul Skodny; John I Mackowiak
Journal:  J Hand Surg Am       Date:  2013-10-17       Impact factor: 2.230

View more
  5 in total

Review 1.  Collagenase clostridium histolyticum in Dupuytren's contracture: a systematic review.

Authors:  Francesco Smeraglia; Angelo Del Buono; Nicola Maffulli
Journal:  Br Med Bull       Date:  2016-05-05       Impact factor: 4.291

2.  DupuytrEn Treatment EffeCtiveness Trial (DETECT): a protocol for prospective, randomised, controlled, outcome assessor-blinded, three-armed parallel 1:1:1, multicentre trial comparing the effectiveness and cost of collagenase clostridium histolyticum, percutaneous needle fasciotomy and limited fasciectomy as short-term and long-term treatment strategies in Dupuytren's contracture.

Authors:  Mikko P Räisänen; Teemu Karjalainen; Harry Göransson; Aleksi Reito; Hannu Kautiainen; Antti Malmivaara; Olli V Leppänen
Journal:  BMJ Open       Date:  2018-03-28       Impact factor: 2.692

3.  Collagenase Clostridium Histolyticum Injection for Dupuytren Contracture: 2-Year Follow-up.

Authors:  Suresh K Nayar; Dennis Pfisterer; John V Ingari
Journal:  Clin Orthop Surg       Date:  2019-08-12

4.  Cost-effectiveness of Recurrent Dupuytren Contracture Treatment.

Authors:  Alfred P Yoon; Robert L Kane; David W Hutton; Kevin C Chung
Journal:  JAMA Netw Open       Date:  2020-10-01

5.  Matrix and cell phenotype differences in Dupuytren's disease.

Authors:  Marike M van Beuge; Evert-Jan P M Ten Dam; Paul M N Werker; Ruud A Bank
Journal:  Fibrogenesis Tissue Repair       Date:  2016-06-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.